Madrigal Pharmaceuticals Reports Third-Quarter 2024 Financial Results and Provides Corporate Updates
Go back to Madrigal Pharmaceuticals Reports Third-Quarter 2024 Financial Results and Provides Corporate Updates| (NASDAQ: MDGL) | Delayed: 531.52 -2.88 (0.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $534.40 | 52 Week High | $18.24 | |||
| Open | $535.08 | 52 Week Low | $6.60 | |||
| Day High | $537.73 | P/E | N/A | |||
| Day Low | $526.65 | EPS | $0.00 | |||
| Volume | 330,615 | |||||

